Subscribe to RSS
DOI: 10.1055/s-0030-1260947
Reaction of β-Vinyl-meso-tetraphenylporphyrin with o-Quinone Methides
Publication History
Publication Date:
14 July 2011 (online)

Abstract
The hetero-Diels-Alder reaction of β-vinyl-meso-tetraphenylporphyrinatozinc(II) with quinone methides generated in situ from Knoevenagel reaction of 2-hydroxy-1,4-naphthoquinone, 4-hydroxycoumarin, and 4-hydroxy-6-methylcoumarin with paraformaldehyde and directly from o-hydroxybenzyl alcohol derivatives is reported.
Key words
porphyrin - o-quinone methide - naphthoquinone - coumarin - o-hydroxybenzyl alcohol - hetero-Diels-Alder
- 1
Handbook of
Porphyrin Science
Vol. 4 and 12:
Kadish K.Smith KM.Guilard R. World Scientific Publishing Company; Singapore: 2010. - 2a
Tomé AC.Neves MGPMS.Cavaleiro JAS. J. Porphyrins Phthalocyanines 2009, 13: 408Reference Ris Wihthout Link - 2b
Cavaleiro JAS.Tomé AC.Neves MGPMS. In Handbook of Porphyrin Science Vol. 2:Kadish K.Smith KM.Guilard R. World Scientific Publishing Company; Singapore: 2010. p.193Reference Ris Wihthout Link - 3a
Ferreira VF.Ferreira SB.da Silva FC. Org. Biomol. Chem. 2010, 8: 4793 ; and references cited thereinReference Ris Wihthout Link - 3b
Salas CO.Faúndez M.Morello A.Maya JD.Tapia RA. Curr. Med. Chem. 2011, 18: 144Reference Ris Wihthout Link - 4a
Kady MM.Brimer L.Furu P.Lemmich S.Nieslen HM.Thiilborg ST.Thastrup O.Christenesen SB. Planta Med. 1992, 58: 334Reference Ris Wihthout Link - 4b
Mahmoud AA.Ahmed AA.Linuma M.Tanaka T. Phytochemistry 1998, 47: 543Reference Ris Wihthout Link - 5a
Florence X.Sebille S.de Tullio P.Lebrun P.Pirotte B. Bioorg. Med. Chem. 2009, 17: 7723Reference Ris Wihthout Link - 5b
Rapposelli S.Breschi MC.Calderone V.Digiacomo M.Martelli A.Testai L.Vanni M.Balsamo A. Eur. J. Med. Chem. 2011, 46: 966Reference Ris Wihthout Link - 6a
Rokita SE. Quinone Methides Wiley; Hoboken: 2009.Reference Ris Wihthout Link - 6b
Tietze LF.Rackelman N. In Multicomponent ReactionsZhu J.Bienaymé H. Wiley-VCH; Weinheim: 2005. p.121Reference Ris Wihthout Link - 6c
da Silva FC.Ferreira SB.Kaiser CR.Pinto AC.Ferreira VF. J. Braz. Chem. Soc. 2009, 20: 1478Reference Ris Wihthout Link - 6d
Ferreira SB.da Silva FC.Bezerra FAFM.Lourenco MCS.Kaiser CR.Pinto AC.Ferreira VF. Arch. Pharm. Chem. Life Sci. 2010, 343: 81Reference Ris Wihthout Link - 6e
Appendino G.Cravotto G.Toma L.Annunziata R.Palmisano G. J. Org. Chem. 1994, 59: 5556Reference Ris Wihthout Link - 6f
Khoshkholgh MJ.Lotfi M.Balalaie S.Rominger F. Tetrahedron 2009, 65: 4228Reference Ris Wihthout Link - 6g
Yadav JS.Reddy BVS.Narsimhaswamy D.Lakshmi PN.Narsimulu K.Srinivasulu G.Kunwar AC. Tetrahedron Lett. 2004, 45: 3493Reference Ris Wihthout Link - 7
Tomé AC.Lacerda PSS.Neves MGPMS.Cavaleiro JAS. Chem. Commun. 1997, 1199 - 8a
Faustino MAF.Neves MGPMS.Tomé AC.Silva AMS.Cavaleiro JAS. ARKIVOC 2005, (ix): 332Reference Ris Wihthout Link - 8b
Oliveira KT.Silva AMS.Tomé AC.Neves MGPMS.Neri CR.Garcia VS.Serra OA.Iamamoto Y.Cavaleiro JAS. Tetrahedron 2008, 64: 8709Reference Ris Wihthout Link - 9
Callot HJ. Tetrahedron 1973, 29: 899 - 11
Wang H.Wang Y.Han KL.Peng XJ. J. Org. Chem. 2005, 70: 4910 - 14
Van de Waters RW.Pettus TRR. Tetrahedron 2002, 58: 5367 ; and references cited therein - 18
Dorrestijn E.Kranenburg M.Ciriano MV.Mulder P. J. Org. Chem. 1999, 64: 3012
References and Notes
General Procedure
for Preparing Compounds 8, 9, and 10a,b
In a round-bottom
flask, equipped with a magnetic stirring bar, a solution of 2-hydroxy-1,4-naphthoquinone
(1, 6.2 mg, 35.5 µmol) [or
4-hydroxycoumarins (2a, 5.7 mg; 2b, 6.2 mg; 35.5 µmol)],
1,4-dioxane (5 mL), paraformaldehyde (8.5 mg, 284 µmol),
and porphyrin 4 (25 mg, 35.5 µmol)
was heated at reflux until consumption of the starting porphyrin 4 (1-48 h). Quinone methide precursors
were added at regular intervals. Dioxane was then removed under
reduced pressure, CHCl3 (50 mL) was added to the residue,
and the mixture was washed with sat. aq NaHCO3 (2 × 20
mL). The organic phase was concentrated under vacuum, and the residual
crude product was purified by column chromatog-raphy on silica gel
and subsequently by preparative TLC using CHCl3 as the
eluent.
Unequivocal proton and carbon assignments
for all compounds were based on two-dimensional COSY, HSQC, and
HMBC experiments.
Data for {2-(5,10-Dioxo-3,4,5,10-tetrahydro-2
H
-benzo[
g
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (8)
¹H NMR
(300 MHz, CDCl3): δ = 2.12-2.32
(m, 2 H, H-3′ and H-4′), 2.54-2.79 (m,
2 H, H-3′ and H-4′), 4.95 (d, J = 8.3 Hz,
1 H, H-2′), 7.49-7.54 (m, 1 H, Hp-Ph),
7.65-7.76 (m, 13 H, Hm,p-Ph, H-7′ and H-8′),
8.07-8.11 (m, 2 H, H-6′ and H-9′), 8.14-8.23
(m, 8 H, Ho-Ph), 8.73 (d, J = 4.8 Hz,
1 H, H-β), 8.89 (d, J = 4.8
Hz, 1 H, H-β), 8.92 (d, J = 4.8
Hz, 1 H, H-β), 8.93 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.8 Hz,
1 H, H-β), 9.12 (s, 1 H, H-3). ¹³C
NMR (75 MHz, CDCl3): δ = 20.2
(C-4′), 29.4 (C-3′), 75.8 (C-2′), 120.4,
121.1, 121.2, 121.5, 121.7 (C-4′a and 2 C-quat), 126.0,
126.2, 126.3, 126.4, 126.6, 126.65, 126.7, 127.5, 128.3 (Co-Ph, Cm,p-Ph, C-6′, C-9′),
131.1; 131.6, 132.0, 132.2, 132.2, 132.5 (C-β), 132.9 (Co-Ph, C-3), 133.0, 133.3, 133.8, 134.4,
134.42, 134.7 (C-7′, C-8′, Co-Ph,
Cm,p-Ph),
142.5, 142.6, 142.7,143.3 (C-1), 145.8, 147.9, 150.3, 150.4, 150.5,
150.6, 150.9, 156.2 (C-10a′), 179.5 (C-5′), 184.5
(C-10′); UV/vis (CHCl3): λmax (log ε) = 424
(4.94), 554 (4.57), 597 (3.96) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C57H37N4O3Zn: 889.2152;
found: 889.2143.
Data for {2-(5,6-Dioxo-3,4,5,6-tetrahydro-2
H
-benzo[
h
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (9)
¹H NMR
(500 MHz, CDCl3): δ = 2.16-2.24
(m, 2 H, H-3′ and H-4′), 2.58-2.61 (m,
1 H, H-3′), 2.71-2.75 (m, 1 H, H-4′),
5.08 (d, J = 10.2
Hz, 1 H, H-2′), 7.47-7.51 (m, 2 H, H-8′,
1 Hp-Ph), 7.55 (dt, J = 7.6,
1.6 Hz, 1 H, H-9′), 7.71-7.81 (m, 12 H, Hm,p-Ph, H-10′),
8.09 (dd, J = 7.6,
1.3 Hz, 1 H, H-7′), 8.16-8.24 (m, 8 H, Ho-Ph), 8.76 (d, J = 4.6
Hz, 1 H, H-β), 8.91 (d, J = 4.6
Hz, 1 H, H-β), 8.95 (s, 2 H, H-12 and H-13), 8.96 (d, J = 4.6 Hz,
1 H, H-β), 8.97 (d, J = 4.6
Hz, 1 H, H-β), 9.14 (d, J = 0.7
Hz, 1 H, H-3). ¹³C NMR (125 MHz, CDCl3): δ = 19.8
(C-4′), 29.8 (C-3′), 76.9 (C-2′), 114.2
(C-4′a), 120.4, 121.1, 121.4, 121.7, 124.2 (C-10′),
126.4, 126.5, 126.6, 126.7, 127.6, 127.7 (Cm,p-Ph), 128.6, 128.7 (Cm,p-Ph, C-7′), 129.9 (C-6′a),
130.6 (C-8′), 131.8, 132.27, 132.30, 132.33, 132.4, 132.43
(C-β), 132.6 (C-3, C-10′a), 133.4, 133.5, 134.36,
134.4, 134.42; 134.5 (C-o), 134.75 (C-9′), 142.3,
142.5, 142.7, 143.2 (C-1), 145.5, 147.7, 150.21, 150.4, 150.57,
150.6, 150.7, 150.8, 163.6 (C-10b′), 178.7 (C-5′),
179.7 (C-6′); UV/vis (CHCl3): λmax (log ε):
424 (4.85), 552 (4.52), 596 (3.96) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C57H37N4O3Zn: 889.2152;
found: 889.2122.
Data for {2-(5-Oxo-2,3,4,5-tetrahydro-2
H
-pyrano[3,2-
c
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (10a)
¹H NMR
(500 MHz, CDCl3): δ = 2.25-2.29
(m, 2 H, H-3′ and H-4′), 2.61-2.67 (m,
2 H, H-3′ and H-4′), 5.04 (d, J = 8.5 Hz,
1 H, H-2′), 7.19 (ddd, J = 8.1,
7.2, 1.0 Hz, 1 H, H-9′), 7.34 (dd, J = 8.5,
1.0 Hz, 1 H, H-7′), 7.40-7.45 (m, 1 H, Hp-Ph), 7.49 (ddd, J = 8.5,
7.2, 1.4 Hz, 1 H, H-8′), 7.71-7.81 (m, 12 H, Hm,p-Ph, H-10′),
8.16-8.23 (m, 8 H, Ho-Ph), 8.75
(d, J = 4.6
Hz, 1 H, H-β), 8.90 (d, J = 4.6
Hz, 1 H, H-β), 8.94 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.6 Hz,
1 H, H-β), 8.97 (d, J = 4.6
Hz, 1 H, H-β), 9.15 (d, J = 0.5
Hz, 1 H, H-3). ¹³C NMR (125 MHz, CDCl3): δ = 20.9
(C-3′), 30.0 (C-4′), 75.9 (C-2′), 101.2
(C-4′a), 115.9 (C-10′a), 116.5 (C-7′),
120.5, 121.1, 121.3, 121.6, 122.5 (C-10′), 123.7 (C-9′),
126.4, 126.5, 126.6, 126.7, 127.6, 127.7, 128.5 (Cm,p-Ph), 131.2 (C-8′), 131.7,
132.3, 132.35, 132.6 (C-β), 133.4, 133.5, 134.37, 134.4,
134.42, 134.47, 134.5 (Co-Ph), 142.3,
142.4, 142.5, 142.7, 143.5 (C-1), 145.6, 147.8, 150.2, 150.4, 150.5, 150.6,
150.9, 152.4 (C-6′a), 160.7 (C-10′b), 163.4 (C-5′). UV/vis
(CHCl3): λmax (log ε): 425
(4.94), 555 (4.54), 596 (4.00) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C56H37N4O3Zn: 877.2152;
found: 877.2116.
General Procedure
for Preparing 11a-c
A mixture of porphyrin 4 (10 mg, 14.2 µmol) and appropriate
benzyl alcohol (3a, 1.7 mg; 3b,
2.2 mg; 14.2 µmol) was refluxed in o-dichlorobenzene
(3 mL) in a sealed tube until consumption of starting porphyrin 4 (monitored by TLC) with addition of quinone
methide precursors at regular intervals. After completion of reaction
(6-26 h) the mixture was loaded on a silica column or preparative
TLC plate and eluted with PE. Further elution with CHCl3 gave
the corresponding adducts.
Data for [2-(Chroman-2-yl)-5,10,15,20-tetraphenylporphyrinato]zinc(II) (11a)
¹H NMR
(300 MHz, CDCl3): δ = 2.14-2.26
(m, 1 H, H-3′), 2.43-2.55 (m, 1 H, H-3′),
2.56-2.74 (m, 2 H, H-4′), 4.95 (d, J = 9.6 Hz,
1 H, H-2′), 6.85-6.94 (m,2 H, H-6′ and
H-8′), 7.07-7.21 (m, 2 H, H-5′ and
H-7′), 7.53-7.59 (m, 1 H, Hp-Ph),
7.68-7.80 (m, 11 H, Hm,p-Ph), 8.15-8.23 (m, 8 H, Ho-Ph), 8.73 (d, J = 4.7
Hz, 1 H, H-β), 8.89 (d, J = 4.7
Hz, 1 H, H-β), 8.91 (d, J = 4.7
Hz, 1 H, H-β), 8.92 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.7 Hz,
1 H, H-β), 9.16 (s, 1 H, H-3). ¹³C NMR
(75 MHz, CDCl3): δ = 26.2
(C-4′), 31.7 (C-3′), 74.2 (C-2′), 117.1
(C-8′), 120.0 (C-6′), 120.6, 120.9, 121.1, 121.5, 122.1
(C-4′a), 126.1, 126.5, 126.55, 127.0, 127.5, 128.1 (C-7′,
Cm,p-Ph),
129.5 (C-5′), 131.5, 131.9, 132.0, 132.1, 132.4, 132.5
(C-β), 133.3, 133.7, 134.3, 134.4, 134.42, 134.6 (Co-Ph), 142.6, 142.7, 142.8, 145.9, 146.5
(C-1), 148.4, 150.0, 150.2, 150.3, 150.5, 150.9, 155.6 (C-8′a).
UV/vis (CHCl3): λmax (log ε):
420 (4.98), 548 (4.59) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C53H37N4Ozn: 809.2253; found:
809.2273.
Data for {2-[8-(2-Hydroxybenzyl)chroman-2-yl)]-5,10,15,20-tetraphenylporphyrinato}zinc(II) (11c)
¹H NMR
(300 MHz, CDCl3): δ = 2.17-2.75
(m, 4 H, H-3′and H-4′), 3.79 (d, J = 14.4
Hz, 1 H, CH2), 3.92 (d, J = 14.4
Hz, 1 H, CH2), 4.97 (dd, J = 10.4,
1.1 Hz, 1 H, H-2′), 6.47 (dd, J = 8.0,
1.1 Hz, 1 H, H-3′′), 6.75 (dt, J = 7.5, 1.1
Hz, 1 H, H-5′′), 6.84 (t, J = 7.4
Hz, 1 H, H-6′), 6.87 (s, 1 H, OH), 6.93-6.97 (m,
2 H, H-5′ and H-4′′),
7.12 (dd, J = 7.4,
1.4 Hz, 1 H, H-7′), 7.20 (dd, J = 7.5,
1.6 Hz, 1 H, H-6′′), 7.52-7.55 (m, 1
H, Hp-Ph), 7.66-7.76 (m, 11
H, Hm,p-Ph),
8.17-8.33 (m, 8 H, Ho-Ph), 8.77
(d, J = 4.7
Hz, 1 H, H-β), 8.89 (d, J = 4.7
Hz, 1 H, H-β), 8.93 (s, 2 H, H-β), 8.95 (s, 2
H, H-β), 9.26 (s, 1 H, H-3). ¹³C
NMR (75 MHz, CDCl3): δ = 26.3
(C-4′), 30.5 (CH2), 31.2 (C-3′), 75.3
(C-2′), 116.4 (C-3′′), 120.3 (C-5′′),
120.6, 120.8 (C-6′), 121.07, 121.13, 121.4, 122.2 (C-4′a),
126.2, 126.4, 126.5 (Cm,p-Ph),
127.0 (Cm,p-Ph,
C-1′′), 127.5, 127.6, 127.8 (C-8′), 128.1
(C-4′′,
C-7′, C-5′,
Cm,p-Ph),
128.2, 130.4 (C-6′′), 130.5; 131.5, 132.06, 132.1,
132.2, 132.4 (C-β), 132.8 (C-3), 133.4, 133.6, 134.4, 134.5,
134.9 (Co-Ph), 142.8, 142.9, 144.9, 145.8, 148.1,
150.2, 150.2, 150.4, 150.4, 150.5, 150.8, 151.6 (C-8′a),
154.0 (C-2′′). UV/vis (CHCl3): λmax (log ε):
420 (5.72), 547 (4.59) nm. HRMS (ESI+): m/z [M]+ calcd
for C60H42N4O2Zn: 914.2594;
found: 914.2583.